These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 24621361)

  • 1. National and sub-national prevalence, trend, and burden of mental disorders and substance abuse in Iran: 1990 - 2013, study protocol.
    Naserbakht M; Djalalinia S; Tayefi B; Gholami M; Eftekhar Ardabili M; Shariat SV; Taban M; Hajebi A; Behtaj F; Sajadi SA; Rahimi-Movaghar A; Moradi-Lakeh M; Farzadfar F
    Arch Iran Med; 2014 Mar; 17(3):182-8. PubMed ID: 24621361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. National and sub-national prevalence, trend, and burden of metabolic risk factors (MRFs) in Iran: 1990 - 2013, study protocol.
    Peykari N; Sepanlou SG; Djalalinia S; Kasaeian A; Parsaeian M; Ahmadvand A; Koohpayehzadeh J; Damari B; Jamshidi HR; Larijani B; Farzadfar F
    Arch Iran Med; 2014 Jan; 17(1):54-61. PubMed ID: 24444064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The trend of national and sub-national burden of gastrointestinal and liver diseases in Iran 1990 to 2013; study protocol.
    Salimzadeh H; Ardeshir Larijani F; Abedian S; Kalantar Motamedi SM; Malekzadeh MM; Mohaghegh H; Sadeghi A; Sepanlou SG; Delavari A; Saberi-Firoozi M; Vahedi H; Rezaei Darzi E; Farzadfar F; Malekzadeh R
    Arch Iran Med; 2014 Jan; 17(1):33-53. PubMed ID: 24444063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. National and sub-national burden of breast cancer in Iran; 1990-2013.
    Naderimagham S; Alipour S; Djalalinia S; Kasaeian A; Noori A; Rahimzadeh S; Modirian M; Khosravi A; Etemad K; Jamshidi HR; Farzadfar F
    Arch Iran Med; 2014 Dec; 17(12):794-9. PubMed ID: 25481316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The global burden of mental, neurological and substance use disorders: an analysis from the Global Burden of Disease Study 2010.
    Whiteford HA; Ferrari AJ; Degenhardt L; Feigin V; Vos T
    PLoS One; 2015; 10(2):e0116820. PubMed ID: 25658103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. National and sub-national prevalence, trend, and burden of end stage renal diseases (ESRD) in Iran 1990-2013; the study protocol.
    Hassannia T; Farzadfar F; Noori A; Moradi-Lakeh M; Delavari F; Jamshidi HR; Djalalinia S; Naderimagham S
    Arch Iran Med; 2014 Dec; 17(12):800-3. PubMed ID: 25481317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. National and sub-national trend of prevalence and burden of dementia in Iran, from 1990 to 2013; study protocol.
    Sharifi F; Najafi B; Fakhrzadeh H; Noroozian M; Naderimagham S; Philp I; Arzaghi SM; Alizadeh M; Shoaee S; Hassannia T; Sheidaei A; Moradi-Lakeh M; Farzadfar F; Larijani B
    Arch Iran Med; 2014 Dec; 17(12):816-20. PubMed ID: 25481320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NASBOD 2013: design, definitions, and metrics.
    Farzadfar F; Delavari A; Malekzadeh R; Mesdaghinia A; Jamshidi HR; Sayyari A; Larijani B
    Arch Iran Med; 2014 Jan; 17(1):7-15. PubMed ID: 24444059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. National and sub-national trend and burden of injuries in Iran, 1990 - 2013: a study protocol.
    Jamshidbeygi E; Rastad H; Qorbani M; Saadat S; Sepidarkish M; Asayesh H; Sepanlou SG; Shokraneh F; Najafi F; Khoramdad M; Maghsodi A; Farzadfar F; Jamshidi HR; Moradi-Lakeh M; Farzadfar F
    Arch Iran Med; 2014 Mar; 17(3):138-45. PubMed ID: 24621356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disability-adjusted Life Years (DALYs) for Mental and Substance Use Disorders in the Korean Burden of Disease Study 2012.
    Lim D; Lee WK; Park H
    J Korean Med Sci; 2016 Nov; 31 Suppl 2(Suppl 2):S191-S199. PubMed ID: 27775257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. National and sub-national environmental burden of disease in Iran from 1990 to 2013-study profile.
    Amini H; Shamsipour M; Sowlat MH; Parsaeian M; Kasaeian A; Hassanvand MS; Kashani H; Saeedi R; Mosaferi M; Nowrouz P; Ahmadnezhad E; Rabiei K; Mesdaghinia A; Yunesian M; Farzadfar F
    Arch Iran Med; 2014 Jan; 17(1):62-70. PubMed ID: 24444065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. National and sub-national burden of infectious diseases in Iran, 1990 to 2013: the study protocol.
    Noori A; Shokoohi M; Moazen B; Moradi G; Naderimagham S; Hajizadeh S; Zohouri Zangeneh A; Gouya MM; Farzadfar F
    Arch Iran Med; 2014 Mar; 17(3):169-75. PubMed ID: 24621359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Burden of Hemoglobinopathies (Thalassemia, Sickle Cell Disorders and G6PD Deficiency) in Iran, 1990-2010: findings from the Global Burden of Disease Study 2010.
    Rezaei N; Naderimagham S; Ghasemian A; Saeedi Moghaddam S; Gohari K; Zareiy S; Sobhani S; Modirian M; Kompani F
    Arch Iran Med; 2015 Aug; 18(8):502-7. PubMed ID: 26265518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prevalence and burden of mental and substance use disorders in Australia: Findings from the Global Burden of Disease Study 2015.
    Ciobanu LG; Ferrari AJ; Erskine HE; Santomauro DF; Charlson FJ; Leung J; Amare AT; Olagunju AT; Whiteford HA; Baune BT
    Aust N Z J Psychiatry; 2018 May; 52(5):483-490. PubMed ID: 29325437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The global epidemiology and burden of psychostimulant dependence: findings from the Global Burden of Disease Study 2010.
    Degenhardt L; Baxter AJ; Lee YY; Hall W; Sara GE; Johns N; Flaxman A; Whiteford HA; Vos T
    Drug Alcohol Depend; 2014 Apr; 137():36-47. PubMed ID: 24559607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. National and sub-national burden of visual impairment in Iran 1990-2013; study protocol.
    Ashrafi E; Mohammadi SF; Fotouhi A; Lashay A; Asadi-lari M; Mahdavi A; Jabbarvand M; Sobhani S; Farzadfar F
    Arch Iran Med; 2014 Dec; 17(12):810-5. PubMed ID: 25481319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. National and sub-national prevalence, trend, and burden of asthma in Iran from 1990 to 2013; the study protocol.
    Varmaghani M; Rashidian A; Kebriaeezadeh A; Moradi-Lakeh M; Moin M; Ghasemian A; Rezaei-Darzi E; Sepanlou SG; Peykari N; Rezaei N; Parsaeian M; Farzadfar F
    Arch Iran Med; 2014 Dec; 17(12):804-9. PubMed ID: 25481318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How did we arrive at burden of disease estimates for mental and illicit drug use disorders in the Global Burden of Disease Study 2010?
    Whiteford HA; Ferrari AJ; Baxter AJ; Charlson FJ; Degenhardt L
    Curr Opin Psychiatry; 2013 Jul; 26(4):376-83. PubMed ID: 23689547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Spanish Burden of Disease 2010: Neurological, mental and substance use disorders.
    Lara E; Garin N; Ferrari AJ; Tyrovolas S; Olaya B; Sànchez-Riera L; Whiteford HA; Haro JM
    Rev Psiquiatr Salud Ment; 2015; 8(4):207-17. PubMed ID: 25435363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. National and sub-national burden of chronic diseases attributable to lifestyle risk factors in Iran 1990 - 2013; study protocol.
    Ghasemian A; Ataie-Jafari A; Khatibzadeh S; Mirarefin M; Jafari L; Nejatinamini S; Parsaeian M; Peykari N; Sobhani S; Jamshidbeygi E; Jamshidi HR; Ebrahimi M; Etemad K; Moradi-Lakeh M; Larijani B; Farzadfar F
    Arch Iran Med; 2014 Mar; 17(3):146-58. PubMed ID: 24621357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.